Gilead Sciences Inc (GILD :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
GILD FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Final Glance: Biotechnology companies 2 hrs ago - The Associated Press
-
Midday Glance: Biotechnology companies 6 hrs ago - The Associated Press
-
-
Early Glance: Biotechnology companies 9 hrs ago - The Associated Press
-
Final Glance: Biotechnology companies 23 hrs ago - The Associated Press
-
Midday Glance: Biotechnology companies 21 May 2013 - The Associated Press
-
Early Glance: Biotechnology companies 21 May 2013 - The Associated Press
-
Cramer's Watch List Ahead of Big Cancer Conference 20 May 2013 - CNBC.com
-
-
Final Glance: Biotechnology companies 20 May 2013 - The Associated Press
MORE FROM CNBC
-
-
Cramer's Watch List Ahead of Big Cancer Conference 20 May 2013 - CNBC.com
-
-
Lightning Round: Starbucks, Gilead & More 16 May 2013 - CNBC.com
-
Jim Cramer's 5 Investing Sweet Spots 14 May 2013 - CNBC.com
-
-
Midday Movers: GILD, BSX, AES & More 13 May 2013 - CNBC.com
-
-
Final Trade: Your First Move for Monday, May 6 03 May 2013 - CNBC.com
MORE FROM OUR PARTNERS
-
Tiger Cub John Griffin's Top Stock Picks For Q2 9 hrs ago - Seeking Alpha
-
Will Influenza A H7N9 Generate Opportunities For Pharma? 21 May 2013 - Seeking Alpha
-
Cramer's Mad Money - The Kids Love Tesla (5/20/13) 21 May 2013 - Seeking Alpha
-
Cramer's Lightning Round - I've Had It With Magnum Hunter (5/16/13) 17 May 2013 - Seeking Alpha
-
This Big Hedge Fund Is Bullish On Big Companies; Should You Be? 13 May 2013 - Seeking Alpha
-
Nailing Big Winners In The Market 09 May 2013 - Seeking Alpha
-
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside 09 May 2013 - Seeking Alpha
-
Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13) 05 May 2013 - Seeking Alpha
-
Cramer's Lightning Round - Akamai Goes From 'Nah' To 'Yeah' (5/2/13) 03 May 2013 - Seeking Alpha
-
Biotech Bulls Can Ignore The Warning Signs At Their Peril 02 May 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare... 20 May 2013 - Seeking Alpha
-
Gilead Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcr... 02 May 2013 - Seeking Alpha
PRESS RELEASES
-
NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 21 May 2013 - PR Newswire
-
European Medicines Agency Validates Gilead's Marketing Application for... 21 May 2013 - Business Wire
-
Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire
-
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire
-
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cas... 20 May 2013 - PR Newswire
-
HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Suppo... 20 May 2013 - PR Newswire
-
eFFECTOR Therapeutics Raises $45 Million in Series A Financing 20 May 2013 - PR Newswire
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conferenc... 17 May 2013 - Business Wire
-
Tens of Thousands to Walk for a Cure for Cystic Fibrosis 17 May 2013 - PR Newswire
-
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Pr... 15 May 2013 - Business Wire
